ArticleBMC women's health2026
Body roundness index and a body shape index and their associations with menopausal symptoms: a comparative cross-sectional study.
Article in BMC women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMenopause is accompanied by a considerable symptom burden, and although body mass index (BMI) is commonly used to assess its association with menopausal symptoms, BMI does not capture central fat distribution. The Body Roundness Index (BRI) and A Body Shape Index (ABSI) specifically reflect central adiposity. This study aimed to investigate the associations of BRI and ABSI with menopausal symptom severity in perimenopausal and menopausal women, and to compare these indices with BMI.
methodsThis cross-sectional study included 638 women aged 44-56 years (319 perimenopausal, 319 menopausal) recruited from a gynaecology outpatient clinic. Menopausal symptom burden was assessed using the Menopause-Specific Quality of Life Scale (MENQOL), and physical activity was evaluated with the International Physical Activity Questionnaire (IPAQ). BMI, BRI, and ABSI were calculated from anthropometric measurements. Kruskal-Wallis test, Spearman correlation analysis, and crude and adjusted multiple linear regression models were used for statistical analysis.
resultsAll three indices showed significant positive associations with total MENQOL scores. In Spearman correlation analysis, ABSI demonstrated the strongest correlation with total symptom burden (r = 0.677, p < 0.01), followed by BRI (r = 0.494, p < 0.01) and BMI (r = 0.332, p < 0.01). In multiple regression models, all associations remained statistically significant after adjustment for age, smoking status, history of chronic disease, BMI (BMI only in BRI and ABSI models) and physical activity. Obese women had the highest MENQOL scores across all subscales in both groups, while overweight women paradoxically showed lower scores than normal-weight women. Physical activity was negatively correlated with total symptom burden (r = - 0.084, p < 0.05), though its independent effect was limited in adjusted models.
conclusionsBRI and ABSI were independently and significantly associated with menopausal symptom burden, with ABSI showing the strongest correlation. Central adiposity indices may add clinically relevant information beyond BMI in menopausal women, and prospective studies are needed to clarify causality.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.